Search

Author/Creator MacGregor, Gordon

1. Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial. Issue 3 (March 2022)

Authors:
Sutharsan, Sivagurunathan; McKone, Edward F; Downey, Damian G; Duckers, Jamie; MacGregor, Gordon; Tullis, Elizabeth; Van Braeckel, Eva; Wainwright, Claire E; Watson, Danie; Ahluwalia, Neil; Bruinsma, Bote G; Harris, Christopher; Lam, Anna P; Lou, Yiyue; Moskowitz, Samuel M; Tian, Simon; Yuan, Jas...
Journal:
Lancet
Issue:
Volume 10:Issue 3(2022)
Page Start:
267
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Inhaled dry powder alginate oligosaccharide in cystic fibrosis: a randomised, double-blind, placebo-controlled, crossover phase 2b study. Issue 4 (19th October 2020)

Authors:
van Koningsbruggen-Rietschel, Silke; Davies, Jane C.; Pressler, Tacjana; Fischer, Rainald; MacGregor, Gordon; Donaldson, Scott H.; Smerud, Knut; Meland, Nils; Mortensen, Jann; Fosbøl, Marie Ø.; Downey, Damian G.; Myrset, Astrid H.; Flaten, Hugo; Rye, Philip D.
Other Names:
author non-byline.; Carroll Mary author non-byline.; Davies Jane author non-byline.; Schwarz Carsten author non-byline.; Derichs Nico author non-byline.; Downey Damian author non-byline.; Eickmeier Olaf author non-byline.; Finstad Pal Leyell author non-byline.; Øbro Fossbøl Marie author non-byli...
Journal:
ERJ open research
Issue:
Volume 6:Issue 4(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study. Issue 7 (July 2021)

Authors:
Flume, Patrick A; Biner, Reta Fischer; Downey, Damian G; Brown, Cynthia; Jain, Manu; Fischer, Rainald; De Boeck, Kris; Sawicki, Gregory S; Chang, Philip; Paz-Diaz, Hildegarde; Rubin, Jaime L; Yang, Yoojung; Hu, Xingdi; Pasta, David J; Millar, Stefanie J; Campbell, Daniel; Wang, Xin; Ahluwalia, Ne...
Journal:
Lancet
Issue:
Volume 9:Issue 7(2021)
Page Start:
733
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Issue 10269 (9th January 2021)

Authors:
Voysey, Merryn; Clemens, Sue Ann Costa; Madhi, Shabir A; Weckx, Lily Y; Folegatti, Pedro M; Aley, Parvinder K; Angus, Brian; Baillie, Vicky L; Barnabas, Shaun L; Bhorat, Qasim E; Bibi, Sagida; Briner, Carmen; Cicconi, Paola; Collins, Andrea M; Colin-Jones, Rachel; Cutland, Clare L; Darton, Thomas...
Journal:
Lancet
Issue:
Volume 397:Issue 10269(2021)
Page Start:
99
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Issue 10277 (6th March 2021)

Authors:
Voysey, Merryn; Costa Clemens, Sue Ann; Madhi, Shabir A; Weckx, Lily Y; Folegatti, Pedro M; Aley, Parvinder K; Angus, Brian; Baillie, Vicky L; Barnabas, Shaun L; Bhorat, Qasim E; Bibi, Sagida; Briner, Carmen; Cicconi, Paola; Clutterbuck, Elizabeth A; Collins, Andrea M; Cutland, Clare L; Darton, T...
Journal:
Lancet
Issue:
Volume 397:Issue 10277(2021)
Page Start:
881
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗